Related Experiment Video
Updated: Aug 15, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Germline BRCA1 pathogenic variants and T cell dysfunction
J Kay1,2, M A Harris1,2, L E Lara Gonzalez1,2
1Department of Research, The Peter MacCallum Cancer Centre, Melbourne, Australia.
Germline BRCA1 variants impair T cell function and reduce T cell counts in breast cancer patients. This T cell dysfunction may impact immunity, cancer development, and immunotherapy response.
Area of Science:
- Immunology
- Oncology
- Genetics
Background:
- Germline BRCA1 (gBRCA1) pathogenic variants (PVs) are a leading cause of inherited breast cancer.
- Previous research indicated homozygous BRCA1 loss impairs T cell-mediated anti-tumor immunity.
- The effect of heterozygous gBRCA1 on human T cell function remained unknown.
Purpose of the Study:
- To investigate the functional consequences of gBRCA1 PVs on human T cells.
- To analyze T cell phenotypes and functions in breast cancer patients with and without gBRCA1 PVs.
- To assess the impact of gBRCA1 PVs on tumor-infiltrating lymphocytes (TILs) in triple-negative breast cancer (TNBC).
Main Methods:
- Collected peripheral blood mononuclear cells (PBMCs) from healthy donors and treatment-naïve early-stage breast cancer patients.
- Activated T cells in vitro and analyzed phenotypic and functional differences.
- Performed T cell receptor (TCR) sequencing and whole exome sequencing on TNBC tumors from gBRCA1 carriers and wild-type (WT) patients.
Main Results:
- Patients with gBRCA1 PVs had significantly lower circulating T cell counts than WT individuals.
- Activated T cells from gBRCA1 carriers showed reduced BRCA1 protein expression, impaired proliferation, and decreased effector molecule production.
- TCR sequencing of TILs from TNBC tumors revealed more hyperexpanded T cell clones in gBRCA1 carriers, correlating with increased tumor mutation burden.
Conclusions:
- Circulating T cells from gBRCA1 carriers exhibit intrinsic dysfunction.
- This T cell dysfunction may influence anti-tumor immunity, cancer development, and progression.
- The findings suggest potential clinical relevance for immunotherapy treatment strategies in gBRCA1 carriers.
More Related Videos
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

